SALL4 and hepatocellular carcinoma: For instance, miR-181b, miR-219, miR-98, and miR-33b have been reported to target directly SALL4, and act astumor suppressors or metastasis suppressors in glioma, hepatocellular carcinoma, and breast cancer, respectively [13,15,32,33].